Inventor · disambiguated record
Michael A. Pleiss
Also filed as: PLEISS MICHAEL A · WELMAKER GREGORY S
86 granted patents·32 pending applications·1,197 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
118 records- 0198US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0295US7378529B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 27, 2008·24 cites·23 claims
- 0395US6492372B1Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Dec 10, 2002·49 cites·6 claims
- 0495US6436904B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Aug 20, 2002·39 cites·32 claims
- 0595US6407066B1Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Jun 18, 2002·52 cites·16 claims
- 0694US7427628B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2006·Granted Sep 23, 2008·23 cites·14 claims
- 0794US6583139B1Compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2000·Granted Jun 24, 2003·56 cites·26 claims
- 0894US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 0993US7008949B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Mar 7, 2006·45 cites·16 claims
- 1093US6903088B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 7, 2005·31 cites·10 claims
- 1193US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 1292US7026328B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Apr 11, 2006·48 cites·18 claims
- 1392US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 1492US6911439B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 28, 2005·28 cites·11 claims
- 1591US7101855B2Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Sep 5, 2006·21 cites·17 claims
- 1691US6974829B2Succinoyl aminopyrazoles and related compoundsELAN PHARM INC·Filed 2003·Granted Dec 13, 2005·33 cites·8 claims
- 1791US6653303B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2003·Granted Nov 25, 2003·16 cites·30 claims
- 1890US10087151B2Substituted benzoxazine and related compoundsTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADSTONE·Filed 2015·Granted Oct 2, 2018·7 cites·16 claims
- 1990US7135477B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Nov 14, 2006·28 cites·9 claims
- 2089US6544978B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 8, 2003·16 cites·32 claims
- 2188US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 2287US7205310B2Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted Apr 17, 2007·11 cites·19 claims
- 2387US6900179B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2001·Granted May 31, 2005·16 cites·13 claims
- 2487US6541466B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 1, 2003·10 cites·32 claims
- 2586US7335663B2Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Feb 26, 2008·19 cites·8 claims
- 2686US7229970B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted Jun 12, 2007·2 cites·11 claims
- 2786US6586602B2Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2002·Granted Jul 1, 2003·10 cites·13 claims
- 2886US6545003B1Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Apr 8, 2003·23 cites·7 claims
- 2985US7973044B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 5, 2011·4 cites·19 claims
- 3085US7452912B2Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Nov 18, 2008·19 cites·11 claims
- 3184US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 3283US7320960B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Jan 22, 2008·5 cites·20 claims
- 3383US6525026B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Feb 25, 2003·9 cites·18 claims
- 3481US7968547B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jun 28, 2011·2 cites·10 claims
- 3581US7538215B2Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted May 26, 2009·2 cites·4 claims
- 3681US6489300B1Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 1998·Granted Dec 3, 2002·40 cites·22 claims
- 3780US7576101B2Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agentsELAN PHARM INC·Filed 2004·Granted Aug 18, 2009·13 cites·26 claims
- 3880US7288526B2Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Oct 30, 2007·5 cites·16 claims
- 3980US6953802B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2001·Granted Oct 11, 2005·13 cites·28 claims
- 4080US6001809AInhibitors of leukocyte adhesionELAN PHARM INC·Filed 1995·Granted Dec 14, 1999·33 cites·13 claims
- 4179US6465513B1Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Oct 15, 2002·12 cites·14 claims
- 4278US7291645B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2003·Granted Nov 6, 2007·7 cites·6 claims
- 4377US7056937B2Sulfonylquinoxalone derivatives as bradykinin antagonistsELAN PHARM INC·Filed 2003·Granted Jun 6, 2006·11 cites·29 claims
- 4476US6410781B1α-aminoacetic acid derivatives-α4β7 receptor antagonistsELAN PHARM INC·Filed 2000·Granted Jun 25, 2002·8 cites·33 claims
- 4576US6291453B14-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Sep 18, 2001·20 cites·32 claims
- 4675US7417152B24-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Granted Aug 26, 2008·8 cites·11 claims
- 4775US7015216B2Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitorsWYETH CORP·Filed 2001·Granted Mar 21, 2006·8 cites·10 claims
- 4875US6559141B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted May 6, 2003·2 cites·32 claims
- 4974US7166580B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jan 23, 2007·2 cites·11 claims
- 5074US2022273778A1Method of inducing antigen-specific tolerance in a subject by administering a composition comprising an apoptotic body surrogate and coupled immunodominant antigenic epitopes associated with autoimmune diseaseUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
Showing the top 50 of 118 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael A. Pleiss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →